文献速递间质性肺疾病

放射组学在系统性硬化相关间质性肺病预后与分子差异评估中的潜力与挑战

The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis.
PubMed 文献 · Eur Respir J · 2022-06-16

本文是对Schniering等发表于European Respiratory Journal研究的读者来信。该研究显示定量放射组学风险评分(qRISSc)可准确预测系统性硬化相关间质性肺病(SSc-ILD)队列的生存,并可从人类逆向转化至动物ILD模型,且与纤维化通路激活相关。这是首个通过跨物种方法验证放射组学生物学意义的里程碑研究,为突破传统放射组学瓶颈提供新思路。

要点

  • qRISSc可准确预测SSc-ILD队列的生存。
  • qRISSc可从人类逆向转化至动物ILD模型。
  • qRISSc与纤维化通路激活相关。

核心结论

  • 放射组学风险评分在评估SSc-ILD预后和分子差异方面有前景但存在挑战。
  • qRISSc可准确预测SSc-ILD队列的生存。
  • qRISSc与纤维化通路激活相关,并通过跨物种方法验证了放射组学生物标志物的生物学意义。

研究设计与样本

  • 本文为读者来信,评述Schniering等发表于European Respiratory Journal的研究。
  • 原研究采用跨物种方法验证放射组学生物标志物的生物学意义。

主要发现

  • qRISSc可准确预测SSc-ILD队列的生存。
  • qRISSc可从人类逆向转化至动物ILD模型。
  • qRISSc与纤维化通路激活相关。

临床怎么用

  • 放射组学可作为SSc-ILD无创工具用于疾病特征描述、预后分层和肺病理生理评估。

局限性

  • 放射组学在评估SSc-ILD预后和分子差异方面存在挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The radiomic risk score is promising but challenging in the evaluation of prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis. https://bit.ly/3oWg4UO We read with great interest the study by Schniering et al. [1], recently published in the European Respiratory Journal. This study highlighted the potential of radiomics as a non-invasive tool for disease characterisation, prognosis stratification and lung pathophysiology evaluation in systemic sclerosis-associated interstitial lung disease (SSc-ILD). The results demonstrated that quantitative radiomic risk score (qRISSc) could accurately predict survival in SSc-ILD cohorts and was reverse translatable from human to animal ILD and correlated with fibrotic pathway activation. To the best of our knowledge, this is the first landmark study to validate the biological meaning of radiomic biomarkers through a cross-species approach, which may provide new insights into future radiomic works to break through the current bottleneck of traditional radiomics.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Zhang L, Zheng J, Jin Z, et al. The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis. Eur Respir J. 2022. PMID: 35604816. doi:10.1183/13993003.02792-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。